Travere Therapeutics-Wall Street Analysts Believe Travere (TVTX) Could Rally 42.56%: Here's is How to Trade

Travere Therapeutics (TVTX) closed the last trading session at $19.08, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 27.20 indicates a 42.6% upside potential.The mean estimate comprises 15 short-term price targets with a standard deviation of $8.33. While the lowest estimate of$ 18 indicates a 5.7% decline from the current price level, the most optimistic analyst ex ...